ABSTRACT NUMBER: ESOC2026YS49 VALIDATION OF A MACHINE LEARNING MODEL TO PREDICT PATIENT CLINICAL OUTCOME 90 DAYS AFTER STROKE

Abstract Background and aims Stroke remains a leading cause of disability and mortality worldwide. Despite successful mechanical thrombectomy (MT), up to 40–50% of patients do not achieve good functional recovery. Accurate early prediction of functional outcome, measured by the modified Rankin Scale (mRS), is therefore essential. The RCP-SEVILLA project (Revival and Consolidation of a database Platform - Stroke Evaluation Via Intelligent Learning for Life-Saving Algorithms) aims to validate a machine learning model to identify patients with good functional prognosis (mRS 0–2) 90 days after stroke. This project is supported by the FIS2026 grant (N°PI25/01957). Methods We developed a supervised classification model using real-world data from the ARTISTA registry (Seville–Huelva Thrombectomy Network), including 3,703 patients treated since 2017. Functional outcome at 90 days was dichotomised as good (mRS 0–2) versus poor (mRS 3–6). Model performance was assessed using ROC analysis in training, internal validation, and external validation cohorts, reporting AUC values. Results The final model was based on logistic regression using 7 clinically relevant variables (age, admission mRS, ASPECTS, NIHSS at 24h, TICA, TSR and blood glucose), achieving an accuracy of 0.82 and an AUC of 0.897 in internal validation. External validation was performed across four independent spanish hospitals, including a total of 2895 samples and, yielding an AUC of 0.911, demonstrating robust generalisability and supporting its potential clinical utility. Future work will explore more advanced AI methods, including neural networks, and extend prediction to three outcome categories (mRS 0–2, 3–5, and 6). Conflict of interest Victor Toscano-Duran: nothing to disclose; Pablo Baena Palomino: nothing to disclose; Asier de Albóniga-Chindurza: nothing to disclose; Marta Aguilar: nothing to disclose; Elena Zapata Arriaza: nothing to disclose; Henry Andrade: nothing to disclose; Angela Gonzalez-Diaz:nothing to disclose; Nazaret Nieto: nothing to disclose; Alejandro González: nothing to disclose.

Authors

Institutions

Publication Details

Journal
European Stroke Journal
Published
2026-05-01
DOI
https://doi.org/10.1093/esj/aakag023.1157
Primary Topic
Acute Ischemic Stroke Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ABSTRACT NUMBER: ESOC2026YS49 VALIDATION OF A MACHINE LEARNING MODEL TO PREDICT PATIENT CLINICAL OUTCOME 90 DAYS AFTER STROKE

P. Palomino, Víctor Toscano-Durán, Nazaret Nieto, Ángela González-Díaz et al.
European Stroke Journal
Acute Ischemic Stroke Management
article

ABSTRACT NUMBER: ESOC2026YS49 VALIDATION OF A MACHINE LEARNING MODEL TO PREDICT PATIENT CLINICAL OUTCOME 90 DAYS AFTER STROKE

P. Palomino, Víctor Toscano-Durán, Nazaret Nieto, Ángela González-Díaz, H. H Andrade, A. VIDAL GONZÁLEZ, Asier de Albóniga-Chindurza, Elena Zapata Arriaza, Marta Aguilar, Norambuena A Christian
article en

Abstract

Abstract Background and aims Stroke remains a leading cause of disability and mortality worldwide. Despite successful mechanical thrombectomy (MT), up to 40–50% of patients do not achieve good functional recovery. Accurate early prediction of functional outcome, measured by the modified Rankin Scale (mRS), is therefore essential. The RCP-SEVILLA project (Revival and Consolidation of a database Platform - Stroke Evaluation Via Intelligent Learning for Life-Saving Algorithms) aims to validate a machine learning model to identify patients with good functional prognosis (mRS 0–2) 90 days after stroke. This project is supported by the FIS2026 grant (N°PI25/01957). Methods We developed a supervised classification model using real-world data from the ARTISTA registry (Seville–Huelva Thrombectomy Network), including 3,703 patients treated since 2017. Functional outcome at 90 days was dichotomised as good (mRS 0–2) versus poor (mRS 3–6). Model performance was assessed using ROC analysis in training, internal validation, and external validation cohorts, reporting AUC values. Results The final model was based on logistic regression using 7 clinically relevant variables (age, admission mRS, ASPECTS, NIHSS at 24h, TICA, TSR and blood glucose), achieving an accuracy of 0.82 and an AUC of 0.897 in internal validation. External validation was performed across four independent spanish hospitals, including a total of 2895 samples and, yielding an AUC of 0.911, demonstrating robust generalisability and supporting its potential clinical utility. Future work will explore more advanced AI methods, including neural networks, and extend prediction to three outcome categories (mRS 0–2, 3–5, and 6). Conflict of interest Victor Toscano-Duran: nothing to disclose; Pablo Baena Palomino: nothing to disclose; Asier de Albóniga-Chindurza: nothing to disclose; Marta Aguilar: nothing to disclose; Elena Zapata Arriaza: nothing to disclose; Henry Andrade: nothing to disclose; Angela Gonzalez-Diaz:nothing to disclose; Nazaret Nieto: nothing to disclose; Alejandro González: nothing to disclose.

European Stroke JournalVol. 11(Supplement_1)
Lockheed Martin (Canada) (CA), Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (ES), Instituto de Biomedicina de Sevilla (ES), Hospital Universitario Virgen del Rocío (ES)
Openalex Percentile: Top 8%
Acute Ischemic Stroke Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.